Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Bruno

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
EJNMMI Research|July 9, 2020
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosisCecilia Marini, Vanessa Cossu, Tiziana Bonifacino, et al.
Biomaterials|August 16, 2015
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusionIrene Cossu, Gianluca Bottoni, Monica Loi, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2021
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapyChiara Brignole, Veronica Bensa, Nuno A Fonseca, et al.
Cell Cycle (Georgetown, Tex.)|October 10, 2008
A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activityRaffaella Ponassi, Barbara Biasotti, Valeria Tomati, et al.
Scientific Reports|October 28, 2017
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL PathwayCecilia Marini, Silvia Bruno, Francesco Fiz, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
EJNMMI Research|July 9, 2020
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosisCecilia Marini, Vanessa Cossu, Tiziana Bonifacino, et al.
Biomaterials|August 16, 2015
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusionIrene Cossu, Gianluca Bottoni, Monica Loi, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2021
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapyChiara Brignole, Veronica Bensa, Nuno A Fonseca, et al.
Cell Cycle (Georgetown, Tex.)|October 10, 2008
A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activityRaffaella Ponassi, Barbara Biasotti, Valeria Tomati, et al.
Scientific Reports|October 28, 2017
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL PathwayCecilia Marini, Silvia Bruno, Francesco Fiz, et al.
Pageof 8